Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2024

Month: June

Request Number: A-2023-001321

Request Summary: The Abbreviated New Drug Submission (ANDS) cover letter of the company (sponsor) who submitted the Mesalazine ANDS.

Disposition: Disclosed in part

Number of pages: 6

Date modified: